What is Paques Biomaterials?
Founded in 2021 and headquartered in El Balk, Netherlands, Paques Biomaterials is at the forefront of manufacturing and selling Polyhydroxyalkanoates (PHA) derived from industrial and municipal waste streams. This innovative approach positions the company as a key player in the circular economy, transforming waste into valuable bioplastics.
How much funding has Paques Biomaterials raised?
Paques Biomaterials has raised a total of $15.2M across 1 funding round:
Other Financing Round
$15.2M
Other Financing Round (2024): $15.2M with participation from Nom and Invest-NL
Key Investors in Paques Biomaterials
Nom
The NOM is the investment agency for the Northern Netherlands, focused on providing financial means and active support to foster company growth and stimulate innovative entrepreneurship with a long-term commitment.
Invest-NL
Invest-NL is the national financing and development institution dedicated to accelerating and financing societal transitions in the Netherlands, providing capital and expertise for sustainable and innovative solutions where the market hesitates.
What's next for Paques Biomaterials?
The recent major strategic investment signals a pivotal growth phase for Paques Biomaterials. This capital is expected to accelerate the scaling of its production capabilities and expand its market reach for PHA bioplastics. The company's focus on waste valorization aligns with increasing global demand for sustainable alternatives to conventional plastics, suggesting a strong trajectory for future development and market penetration.
See full Paques Biomaterials company page
